Reduced Levels and Disrupted Biosynthesis Pathways of Plasma Free Fatty Acids in First-Episode Antipsychotic-Naïve Schizophrenia Patients is a research paper published in Frontiers in Neuroscience (2020). On theSindex it has a DataRank of 0.396. It has been cited 13 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.396
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCRR NIH HHS
Grant: M01 RR000056
NIMH NIH HHS
Grant: R03 MH070434
NIMH NIH HHS
Grant: K02 MH001180
NIMH NIH HHS
Grant: P50 MH045156
CSRD VA
Grant: I01 CX000110
NIMH NIH HHS
Grant: R01 MH064023
NIMH NIH HHS
Grant: R01 MH058141
NIMH NIH HHS
Grant: R21 MH102565
National Institutes of Health
Grant: 2K02MH001180-06A1
BRAIN MATURATION AND VULNERABILITY TO SCHIZOPHRENIA
National Institutes of Health
Grant: 5R03MH070434-02
Niacin Sensitivity and Fatty Acids in Schizophrenia
National Institutes of Health
Grant: 1I01CX000110-01A1
Phospholipid-Arachidonate-Eicosanoid Signaling in Schizophrenia
National Institutes of Health
Grant: 5R01MH058141-02
MEMBRANE DEFICITS AND OUTCOME IN SCHIZOPHRENIA
National Institutes of Health
Grant: 3M01RR000056-38S3
PRE SURGICAL O6 BENZYLGUANINE TREATMENT OF PTS W/ MALIGNANT GLIOMA
National Institutes of Health
Grant: 1R21MH102565-01
Evaluation of a Physiologic Marker for Schizophrenia in First-Episode Psychosis
FWCI
0.90
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals